Determinants of therapeutic resistance in glioblastomas: Lessons learned from RTOG 0211 and beyond. Background: Due to an ability to reverse blood-brain barrier permeability, antiangiogenic agents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback